Ming Hou
Shandong University · 385 works · 10,102 citations · h-index 52
Top works
- Updated international consensus report on the investigation and management of primary immune thrombocytopenia
- High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial
- Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
- Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
- Mycophenolate mofetil (MMF) for the treatment of steroid‐resistant idiopathic thrombocytopenic purpura
- Cell‐mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura
- Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
- Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura
- Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti‐platelet GPIIbIIIa versus GPIbα antibodies
- Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study
- Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using flow cytometry, a whole platelet ELISA, and an antigen capture ELISA
- A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP
- A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy
- Immune thrombocytopenia ( ITP ) World Impact Survey ( I‐WISh ): Impact of ITP on health‐related quality of life
- Correction of Th1-dominant Cytokine Profiles by High-dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura
- How we treat primary immune thrombocytopenia in adults
- Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040
- Elevated Interleukin-21 Correlated to Th17 and Th1 Cells in Patients with Immune Thrombocytopenia
- Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies
- A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia